Upregulated expression of hITF in Crohn's disease and screening of hITF Interactant by a yeast two-hybrid system

Huaxiu Shi1, Jianlin Ren, Hongzhi Xu

  • 1Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.

Abstract

Insights

Human intestinal trefoil factor (hITF) mRNA expression increases in Crohn's disease. This study identified ZNF193 and AKR1C1 as interacting proteins, suggesting a role for hITF in mucosal repair.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Immunology

Background:

  • Crohn's disease (CD) is a chronic inflammatory bowel disease.
  • The role of human intestinal trefoil factor (hITF) in CD pathogenesis is not fully understood.
  • Identifying hITF interacting proteins may elucidate its function in intestinal mucosal integrity.

Purpose of the Study:

  • To quantify hITF mRNA expression in CD patients.
  • To identify proteins interacting with hITF using a yeast two-hybrid system.
  • To explore the mechanism of hITF in protecting the intestinal mucosa.

Main Methods:

  • Quantitative real-time polymerase chain reaction (qRT-PCR) for hITF mRNA expression analysis.
  • Yeast two-hybrid system screening with a human jejunal cDNA library to identify hITF interacting proteins.
  • Co-immunoprecipitation (Co-IP) to validate protein interactions.

Main Results:

  • hITF mRNA expression was significantly elevated in CD patients compared to controls.
  • Yeast two-hybrid screening identified ZNF193 and AKR1C1 as potential hITF interacting proteins.
  • Co-IP confirmed the interaction between hITF and both ZNF193 and AKR1C1.

Conclusions:

  • hITF mRNA is upregulated in Crohn's disease.
  • ZNF193 and AKR1C1 interact with hITF, as confirmed by yeast two-hybrid and Co-IP.
  • These interactions suggest hITF may play a role in mucosal repair mechanisms in CD.

Related Concept Videos